EXAGEN INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EXAGEN INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-06-30 was 0.00 shares.
- EXAGEN INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-03-31 was 96.02K shares, a 19.20% increase year-over-year.
- EXAGEN INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-12-31 was 0.00 shares.
- EXAGEN INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-09-30 was 76.78K shares.
- EXAGEN INC. stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 157.34K shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 172.81K shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 96.02K shares 10-Q · filed 2026-05-11 | 172.81K shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 157.34K shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 76.78K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | |
| 2025-03-31 | 80.55K shares 10-Q · filed 2025-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |